Immatics N.V.
NASDAQ:IMTXBiotechnology
+$0.15 today
- Market cap
- $890.33M
- Beta
- 1.30
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.59
Volume 0.99M
Average 0.46M
Returns on capital
Immatics N.V. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-40.6%
avg -37.6%
ROIC
-34.3%
avg -43.6%
ROA
-34.9%
avg -32.7%
Analysis
ROIC is currently the strongest return metric at -34.3% versus its period average of -43.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Harpreet Singh | Chief Executive Officer, MD, Member of Management Board & Executive Director | EUR 970.64K | 51 | — | — |
James Pepin | General Counsel & Corporate Secretary | — | — | — | — |
Carsten Reinhardt | Chief Development Officer | — | 59 | — | — |
Hans-Georg Rammensee | Co-Founder & Member of the Scientific Advisory Board | — | — | — | — |
Toni Weinschenk | Co-Founder & Chief Innovation Officer | — | 56 | — | — |
Venkat Ramanan | Chief Financial Officer | — | 56 | 350.00K | 0.26% |
Ephraim Hofsäß | Vice President of SEC Reporting & Accounting | — | — | — | — |
Steffen Walter | Chief Operations Officer | — | 49 | — | — |
Amie Krause | Chief People Officer | — | 53 | — | — |
Lauren Schroeder | Vice President of Marketing | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 18, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$7.50M
Sells
0
$0.00
Net Transaction Value
+$7.50M
Net buying
Most Active
PERCEPTIVE ADVISORS LLC
1 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 26, 26Aug 26, 2026 | PERCEPTIVE ADVISORS LLC Indirect | Buy | $7.5M$7,499,991.40 |
Summary
Insiders reported 1 buys worth $7.50M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $7.50M. PERCEPTIVE ADVISORS LLC was the most active insider with 1 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | -34.6% | +55.7% (5yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at -34.6% over three years. Forward estimates point to Revenue at +55.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Immatics N.V. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about IMTX's management, answered from reported figures.
Who manages IMTX?
Immatics N.V. (IMTX) lists 10 active executives. The top listed executive is James Pepin, General Counsel & Corporate Secretary.
Are IMTX insiders buying or selling?
Recent insider activity shows net buying of $13.14M.
Continue the stock analysis
Jump to another research area for this company.